BIIB Stock Skyrockets as Investors Bet on Alzheimer’s Candidate
BIIB stock is having one of its biggest one-day gains in the past few years as Biogen Inc (NASDAQ:BIIB) plans on pursuing a regulatory application for the Alzheimer’s disease candidate aducanumab in the United States. …
JNJ Stock Tanks Following Baby Powder Recall Over Asbestos Concerns
JNJ stock is down 6% today after Johnson & Johnson (NYSE:JNJ) recalled a single lot of its baby powder as a precaution after US government testing found trace amounts of asbestos in one bottle purchased …
MDCO Stock Hits 2-Year High After Robust Clinical Data
When pharmaceutical companies manage to get highly positive results from clinical trials of one of their more important products, then it almost always has a positive impact on the stock price, and that is what …
JNJ Stock Slides As Company Loses Landmark Opioid Case
Johnson & Johnson (NYSE:JNJ) has lost a landmark case regarding its role in the opioid crisis, causing further losses for JNJ stock.
An Oklahoma judge has ordered the pharmaceutical heavyweight to pay $572 …
CELG Stock is Up 45% YTD: What Should You Know?
CELG stock is currently on a good run of good news in 2019 after a few years of bad news from Celgene Corporation (NASDAQ:CELG).
In May, the company secured US Food and Drug …
Mylan Stock Drops 8.5% After US Lawmakers Slam MYL
Mylan stock has dropped 8.5% today after Mylan (NASDAQ:MYL) was slammed by two prominent US lawmakers.
Coordinated Obstruction
The company, along with two other major pharmaceuticals, is being investigated as part of an …
Amgen Stock Continues to Rise Following Court Ruling
Amgen stock (NASDAQ:AMGN) continued its positive run today, gaining 4.9% after the judge upheld two of the firm’s key patents.
On Friday, a New Jersey judge ruled in Amgen’s favor in a dispute …
BMY Stock Drops 7% After Delaying Acquisition of Celgene Corporation
Similar to cannabis stocks, Bristol-Myers Squibb (NYSE:BMY) has not had a solid start to the week, and neither has Celgene Corporation (NASDAQ:CELG). These two, however, have something to do with one another. On news that …
BHC Stock Closes Up 9%: Bausch 2019 Outlook Increased After Successful Q1
On Monday, May 6, BHC stock jumped nearly 10% after Bausch Health Companies (TSX:BHC) announced its Q1 2019 results and increased its 2019 outlook.
Here’s what we know.
BHC Stock Up On … Read
US Drug Companies Raise Med Prices Despite President Trump Pressure
2019 is not kicking off to a great start for most Americans. US drug companies kicked off the year implementing price increases on more than 250 prescription drugs—despite pressure from President Trump to not do …